Cadmium levels in human breast tissue and estradiol serum levels: Is there a connection?
Cadmium (Cd), one of the most abundant environmental pollutants, is considered to have endocrine disrupting properties. However, data on the dose-response relationship between Cd dose and levels of hormones have been insufficiently studied, especially in human data sets. Thus, the aim of this study was to determine the possibility of analyzing data obtained from a case-control study in female patients with benign/malignant breast tumors, using the Benchmark dose (BMD) concept. The collected data on Cd levels in breast tissue and estrogen serum levels were processed in PROAST software using different variables. The dose-response relationship between the internal dose of Cd and estradiol levels in the serum was investigated and BMD intervals were calculated. The dose-response relationship between the Cd concentration in breast tissue and the estradiol serum level was shown, indicating lower estradiol serum levels as a consequence of higher Cd concentrations in breast tissue. As one of the few studies analyzing human data using the BMD approach, these findings could have a pivotal role in dose response analysis of data collected from human studies.
Satarug S, Gobe GC, Vesey DA, Phelps KR. Cadmium and lead exposure, nephrotoxicity, and mortality. Toxics. 2020;8(4):1–42.
Chedrese P, Piasek M, Henson M. Cadmium as an Endocrine Disruptor in the Reproductive System. Immunol Endocrn Metab Agents Med Chem. 2006;6(1):27–35.
Nasiadek M, Danilewicz M, Klimczak M, Stragierowicz J, Kilanowicz A. Subchronic Exposure to Cadmium Causes Persistent Changes in the Reproductive System in Female Wistar Rats. Oxid Med Cell Longev. 2019;2019:1–17.
Renieri EA, Sfakianakis DG, Alegakis AA, Safenkova IV., Buha A, Matović V, et al. Nonlinear responses to waterborne cadmium exposure in zebrafish. An in vivo study. Environ Res. 2017;157:173–81.
Buha A, Matovic V, Antonijevic B, Bulat Z, Curcic M, Renieri EA, et al. Overview of cadmium thyroid disrupting effects and mechanisms. Int J Mol Sci. 2018;19(5):1501.
Buha A, Jugdaohsingh R, Matovic V, Bulat Z, Antonijevic B, Kerns JG, et al. Bone mineral health is sensitively related to environmental cadmium exposure- experimental and human data. Environ Res. 2019;176:108539.
Buha A, Djukić-Ćosić D, Ćurčić M, Bulat Z, Antonijević B, Moulis JM et al. Emerging Links between Cadmium Exposure and Insulin Resistance: Human, Animal, and Cell Study Data. Toxics. 2020;8(3):63.
Buha A, Baralić K, Djukic-Cosic D, Bulat Z, Tinkov A, Panieri E, et al. The role of toxic metals and metalloids in nrf2 signaling. Antioxidants. 2021;10(5):603.
Djordjevic VR, Wallace DR, Schweitzer A, Boricic N, Knezevic D, Matic S, et al. Environmental cadmium exposure and pancreatic cancer: Evidence from case control, animal and in vitro studies. Environ Int. 2019;128:353–61.
Đukić-Ćosić D, Baralić K, Javorac D, Djordjevic AB, Bulat Z. An overview of molecular mechanisms in cadmium toxicity. Curr Opin Toxicol. 2020;19:56–62.
Wallace DR, Taalab YM, Heinze S, Tariba Lovaković B, Pizent A, Renieri E, et al. Toxic-Metal-Induced Alteration in miRNA Expression Profile as a Proposed Mechanism for Disease Development. Cells. 2020;9(4):901.
Fransson MN, Barregard L, Sallsten G, Akerstrom M, Johanson G. Physiologically-based toxicokinetic model for cadmium using markov-chain monte carlo analysis of concentrations in blood, urine, and kidney cortex from living kidney donors. Toxicol Sci. 2014;141(2):365–76.
Andjelkovic M, Djordjevic AB, Miljakovic EA, Javorac D, Colakovic N, Opric S, et al. Cadmium tissue level in women diagnosed with breast cancer – A case control study. Environ Res. 2021;199:111300.
Bergman Å, Heindel J, Jobling S, Kidd K, Zoeller RT. State-of-the-science of endocrine disrupting chemicals, 2012. Toxicol Lett. 2012; 211S:S2-S3
EFSA Scientific Committee “Scientific Opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment”. EFSA J. 2013;11(3):3132
Goumenou M, Djordjevic BA, Vassilopoulou L, Tsarsakis AM. Endocrine disruption and human health risk assessment in the light of real-life risk simulation. In: Toxicological Risk Assessment and Multi-System Health Impacts from Exposure; 2021. p. 147–62.
Hardy A, Benford D, Halldorsson T, Jeger M, Knutsen K, More S, et al. Update: use of the benchmark dose approach in risk assessment. EFSA 2017;15(1):4658.
Mayfield DB, Skall DG. Benchmark dose analysis framework for developing wildlife toxicity reference values. Environ Toxicol Chem. 2018;37(5):1496–508.
Edler L, Hart A, Greaves P, Carthew P, Coulet M, Boobis A, et al. Selection of appropriate tumour data sets for Benchmark Dose Modelling (BMD) and derivation of a Margin of Exposure (MoE) for substances that are genotoxic and carcinogenic: considerations of biological relevance of tumour type, data quality and uncertainty assessment. Food Chem Toxicol. 2014;70:264-289.
Grandjean P, Budtz- Jørgensen E. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health. 2013;12(1):1-7.
Lin T, Xiao-Ting L, Ai G, Qui-Ying L, Tai-Yi J. Application of Benchmark Dose for Occupational Epidemiology in Lead Exposure. Toxicol Mech Methods. 2008;18:363-367.
Jin T, Wu X, Tang Y, Nordberg M, Bernard A, Ye T, et al. Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China. Biometals. 2004;17:525-530.
Nagata C, Konishi K, Goto Y, Tamura T, Wada K, Hayashi M, et al. Associations of urinary cadmium with circulating sex hormone levels in pre- and postmenopausal Japanese women. Environ Res. 2016;150:82–87.
Ali I, Engström A, Vahter M, Skerfving S, Lundh T, Lidfeldt J, et al. Associations between cadmium exposure and circulating levels of sex hormones in postmenopausal women. Environ Res. 2014;134:265–269.
Hernandez AF, Buha A, Constantin C, Wallace DR, Sarigiannis D, Neagu M, et al. Critical assessment and integration of separate lines of evidence for risk assessment of chemical mixtures. Arch Toxicol. 2019;93:2741-2757.
Kohn MC, Melnick RL. Biochemical origins of the non-monotonic receptor-mediated dose-response. J Mol Endocrinol. 2002;29(1):113–23.
Silva N, Peiris-John R, Wickremasinghe R, Senanayake H, Sathiakumar N. Cadmium a metalloestrogen: Are we convinced? J Appl Toxicol. 2012;32(5):318–32.